GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (MIL:REC) » Definitions » Cyclically Adjusted Price-to-FCF

Recordati SpA (MIL:REC) Cyclically Adjusted Price-to-FCF : 45.82 (As of Sep. 21, 2024)


View and export this data going back to 1984. Start your Free Trial

What is Recordati SpA Cyclically Adjusted Price-to-FCF?

As of today (2024-09-21), Recordati SpA's current share price is €49.94. Recordati SpA's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 was €1.09. Recordati SpA's Cyclically Adjusted Price-to-FCF for today is 45.82.

The historical rank and industry rank for Recordati SpA's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MIL:REC' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 36.75   Med: 55.9   Max: 91.17
Current: 46.33

During the past years, Recordati SpA's highest Cyclically Adjusted Price-to-FCF was 91.17. The lowest was 36.75. And the median was 55.90.

MIL:REC's Cyclically Adjusted Price-to-FCF is ranked worse than
66.89% of 293 companies
in the Drug Manufacturers industry
Industry Median: 29.71 vs MIL:REC: 46.33

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Recordati SpA's adjusted free cash flow per share data for the three months ended in Jun. 2024 was €0.501. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €1.09 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Recordati SpA Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Recordati SpA's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Cyclically Adjusted Price-to-FCF Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.86 78.88 75.12 39.00 48.99

Recordati SpA Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.34 44.62 48.99 48.80 44.81

Competitive Comparison of Recordati SpA's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Recordati SpA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Cyclically Adjusted Price-to-FCF falls into.



Recordati SpA Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Recordati SpA's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=49.94/1.09
=45.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Recordati SpA's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.501/120.7000*120.7000
=0.501

Current CPI (Jun. 2024) = 120.7000.

Recordati SpA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 0.272 99.814 0.329
201412 0.165 99.721 0.200
201503 0.171 99.814 0.207
201506 0.289 100.279 0.348
201509 0.370 100.000 0.447
201512 0.192 99.814 0.232
201603 0.287 99.600 0.348
201606 0.237 99.900 0.286
201609 0.346 100.100 0.417
201612 0.174 100.300 0.209
201703 0.382 101.000 0.457
201706 -0.913 101.100 -1.090
201709 0.165 101.200 0.197
201712 0.136 101.200 0.162
201803 0.334 101.800 0.396
201806 0.369 102.400 0.435
201809 0.449 102.600 0.528
201812 0.154 102.300 0.182
201903 0.219 102.800 0.257
201906 0.141 103.100 0.165
201909 0.488 102.900 0.572
201912 -1.445 102.800 -1.697
202003 0.333 102.900 0.391
202006 0.221 102.900 0.259
202009 0.356 102.300 0.420
202012 0.391 102.600 0.460
202103 0.276 103.700 0.321
202106 0.423 104.200 0.490
202109 0.692 104.900 0.796
202112 0.541 106.600 0.613
202203 0.467 110.400 0.511
202206 0.316 112.500 0.339
202209 0.546 114.200 0.577
202212 0.417 119.000 0.423
202303 0.432 118.800 0.439
202306 0.691 119.700 0.697
202309 -0.904 120.300 -0.907
202312 0.268 119.700 0.270
202403 0.679 120.200 0.682
202406 0.501 120.700 0.501

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Recordati SpA  (MIL:REC) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Recordati SpA Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA Business Description

Industry
Traded in Other Exchanges
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA Headlines